dynavax

  1. T

    Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTM

    Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of a large-scale Phase 3 trial designed to demonstrate the lot-to-lot consistency of commercial vaccine and to complete the safety database for HEPLISAV™, the Company's investigational adult hepatitis B vaccine. This study and...
Back
Top